Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 61 entries
Sorted by: Best Match Show Resources per page
Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both?.

Seminars in radiation oncology

Postmus PE.
PMID: 10717129
Semin Radiat Oncol. 1995 Jan;5(1):69-73. doi: 10.1054/SRAO00500069.

Brain metastasis is one of the most troublesome forms of metastatic disease in small cell lung cancer and is seen in more than half of the patients during the course of their disease. Treatment is very often indicated to...

Cite
Postmus PE. Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both?. Semin Radiat Oncol. 1995;5(1):69-73doi: 10.1054/SRAO00500069.
Postmus, P. E. (1995). Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both?. Seminars in radiation oncology, 5(1), 69-73. https://doi.org/10.1054/SRAO00500069
Postmus. "Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both?." Seminars in radiation oncology vol. 5,1 (1995): 69-73. doi: https://doi.org/10.1054/SRAO00500069
Postmus PE. Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both?. Semin Radiat Oncol. 1995 Jan;5(1):69-73. doi: 10.1054/SRAO00500069. PMID: 10717129.
Copy Download .nbib Format: NLM
Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine.

European journal of internal medicine

Nanayakkara PW, de Jong E, Postmus PE.
PMID: 15581755
Eur J Intern Med. 2004 Nov;15(7):470-472. doi: 10.1016/j.ejim.2004.08.007.

A 36-year-old woman presented with a 2-month history of dry cough, bilateral pain in the upper chest, and low-grade fever. She had a 1-year history of ulcerative colitis (UC), which was treated with mesalazine. Cultures of sputum and bronchoalveolar...

Cite
Nanayakkara PW, de Jong E, Postmus PE. Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine. Eur J Intern Med. 2004;15(7):470-472doi: 10.1016/j.ejim.2004.08.007.
Nanayakkara, P. W., de Jong, E., & Postmus, P. E. (2004). Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine. European journal of internal medicine, 15(7), 470-472. https://doi.org/10.1016/j.ejim.2004.08.007
Nanayakkara, Prabath W B, et al. "Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine." European journal of internal medicine vol. 15,7 (2004): 470-472. doi: https://doi.org/10.1016/j.ejim.2004.08.007
Nanayakkara PW, de Jong E, Postmus PE. Bilateral pulmonary infiltrates in a patient with ulcerative colitis receiving mesalazine. Eur J Intern Med. 2004 Nov;15(7):470-472. doi: 10.1016/j.ejim.2004.08.007. PMID: 15581755.
Copy Download .nbib Format: NLM
Screening and early diagnosis in lung cancer.

Expert review of anticancer therapy

Postmus PE.
PMID: 18925844
Expert Rev Anticancer Ther. 2008 Oct;8(10):1529-31. doi: 10.1586/14737140.8.10.1529.

No abstract available.

Cite
Postmus PE. Screening and early diagnosis in lung cancer. Expert Rev Anticancer Ther. 2008;8(10):1529-31doi: 10.1586/14737140.8.10.1529.
Postmus, P. E. (2008). Screening and early diagnosis in lung cancer. Expert review of anticancer therapy, 8(10), 1529-31. https://doi.org/10.1586/14737140.8.10.1529
Postmus, Pieter E. "Screening and early diagnosis in lung cancer." Expert review of anticancer therapy vol. 8,10 (2008): 1529-31. doi: https://doi.org/10.1586/14737140.8.10.1529
Postmus PE. Screening and early diagnosis in lung cancer. Expert Rev Anticancer Ther. 2008 Oct;8(10):1529-31. doi: 10.1586/14737140.8.10.1529. PMID: 18925844.
Copy Download .nbib Format: NLM
[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival].

Nederlands tijdschrift voor geneeskunde

Slotman BJ, Faivre-Finn C, Kramer GW, Rankin E, Snee M, Hatton M, Postmus PE, Collette L, Musat E, Senan S.
PMID: 18549175
Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):1000-4.

OBJECTIVE: To determine the effect of prophylactic cranial irradiation (PCI) in patients with extensive-disease small-cell lung cancer (ED-SCLC) who responded to chemotherapy.DESIGN: Randomised, controlled clinical trial; phase III study (EORTC nr 08993-22993; www.clinicaltrials.gov, nr NCT00016211).METHOD: Patients aged 18-75 years...

Cite
Slotman BJ, Faivre-Finn C, Kramer GW, et al. Profylactische schedelbestraling bij patiënten met uitgebreid kleincellig longcarcinoom dat reageert op chemotherapie: minder symptomatische hersenmetastasen en betere overleving. [Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Ned Tijdschr Geneeskd. 2008;152(17):1000-4
Slotman, B. J., Faivre-Finn, C., Kramer, G. W., Rankin, E., Snee, M., Hatton, M., Postmus, P. E., Collette, L., Musat, E., & Senan, S. (2008). Profylactische schedelbestraling bij patiënten met uitgebreid kleincellig longcarcinoom dat reageert op chemotherapie: minder symptomatische hersenmetastasen en betere overleving. [Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Nederlands tijdschrift voor geneeskunde, 152(17), 1000-4.
Slotman, B J, et al. "Profylactische schedelbestraling bij patiënten met uitgebreid kleincellig longcarcinoom dat reageert op chemotherapie: minder symptomatische hersenmetastasen en betere overleving." [Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Nederlands tijdschrift voor geneeskunde vol. 152,17 (2008): 1000-4.
Slotman BJ, Faivre-Finn C, Kramer GW, Rankin E, Snee M, Hatton M, Postmus PE, Collette L, Musat E, Senan S. Profylactische schedelbestraling bij patiënten met uitgebreid kleincellig longcarcinoom dat reageert op chemotherapie: minder symptomatische hersenmetastasen en betere overleving. [Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]. Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):1000-4. Dutch. PMID: 18549175.
Copy Download .nbib Format: NLM
Website visitors asking questions online to lung cancer specialists: what do they want to know?.

Interactive journal of medical research

Schook RM, Linssen C, Festen J, Schramel FM, Lammers E, Zaanen P, Postmus PE.
PMID: 23919980
Interact J Med Res. 2013 Aug 06;2(2):e15. doi: 10.2196/ijmr.1749.

BACKGROUND: In 2003 the Dutch Lung Cancer Information Centre (Longkanker Informatie Centrum) launched a website containing information on lung cancer accessible to anyone.OBJECTIVE: Our study aim was to inventorize the information needs of the visitors of this website by...

Cite
Schook RM, Linssen C, Festen J, et al. Website visitors asking questions online to lung cancer specialists: what do they want to know?. Interact J Med Res. 2013;2(2):e15doi: 10.2196/ijmr.1749.
Schook, R. M., Linssen, C., Festen, J., Schramel, F. M., Lammers, E., Zaanen, P., & Postmus, P. E. (2013). Website visitors asking questions online to lung cancer specialists: what do they want to know?. Interactive journal of medical research, 2(2), e15. https://doi.org/10.2196/ijmr.1749
Schook, Romane M, et al. "Website visitors asking questions online to lung cancer specialists: what do they want to know?." Interactive journal of medical research vol. 2,2 (2013): e15. doi: https://doi.org/10.2196/ijmr.1749
Schook RM, Linssen C, Festen J, Schramel FM, Lammers E, Zaanen P, Postmus PE. Website visitors asking questions online to lung cancer specialists: what do they want to know?. Interact J Med Res. 2013 Aug 06;2(2):e15. doi: 10.2196/ijmr.1749. PMID: 23919980; PMCID: PMC3742407.
Copy Download .nbib Format: NLM
Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study.

OncoTargets and therapy

Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H.
PMID: 30122949
Onco Targets Ther. 2018 Aug 06;11:4573-4582. doi: 10.2147/OTT.S170722. eCollection 2018.

BACKGROUND: Nintedanib in combination with docetaxel is approved in the European Union and other countries for the treatment of patients with advanced non-small-cell lung cancer (NSCLC) of adenocarcinoma histology after first-line chemotherapy, based on the overall survival findings of...

Cite
Reck M, Mellemgaard A, Novello S, et al. Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. Onco Targets Ther. 2018;11:4573-4582doi: 10.2147/OTT.S170722.
Reck, M., Mellemgaard, A., Novello, S., Postmus, P. E., Gaschler-Markefski, B., Kaiser, R., & Buchner, H. (2018). Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. OncoTargets and therapy, 114573-4582. https://doi.org/10.2147/OTT.S170722
Reck, Martin, et al. "Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study." OncoTargets and therapy vol. 11 (2018): 4573-4582. doi: https://doi.org/10.2147/OTT.S170722
Reck M, Mellemgaard A, Novello S, Postmus PE, Gaschler-Markefski B, Kaiser R, Buchner H. Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. Onco Targets Ther. 2018 Aug 06;11:4573-4582. doi: 10.2147/OTT.S170722. eCollection 2018. PMID: 30122949; PMCID: PMC6084077.
Copy Download .nbib Format: NLM
Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer.

Histopathology

Hondelink LM, Hüyük M, Postmus PE, Smit VTHBM, Blom S, von der Thüsen JH, Cohen D.
PMID: 34786761
Histopathology. 2021 Nov 16; doi: 10.1111/his.14571. Epub 2021 Nov 16.

AIMS: Immunohistochemical programmed death-ligand 1 (PD-L1) staining to predict responsiveness to immunotherapy in patients with advanced non-small cell lung cancer (NSCLC) has several drawbacks: a robust gold standard is lacking, and there is substantial interobserver and intraobserver variance, with...

Cite
Hondelink LM, Hüyük M, Postmus PE, et al. Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer. Histopathology. 2021;doi: 10.1111/his.14571.
Hondelink, L. M., Hüyük, M., Postmus, P. E., Smit, V. T. H. B. M., Blom, S., von der Thüsen, J. H., & Cohen, D. (2021). Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer. Histopathology, . https://doi.org/10.1111/his.14571
Hondelink, Liesbeth M, et al. "Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer." Histopathology vol. (2021). doi: https://doi.org/10.1111/his.14571
Hondelink LM, Hüyük M, Postmus PE, Smit VTHBM, Blom S, von der Thüsen JH, Cohen D. Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer. Histopathology. 2021 Nov 16; doi: 10.1111/his.14571. Epub 2021 Nov 16. PMID: 34786761.
Copy Download .nbib Format: NLM
Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia.

Diagnostic and therapeutic endoscopy

Venmans BJ, Van Boxem TJ, Smit EF, Postmus PE, Sutedja TG.
PMID: 18493485
Diagn Ther Endosc. 1999;5(2):77-84. doi: 10.1155/DTE.5.77.

The aim of the study was to determine whether use of fluorescence bronchoscopy improves the detection of preinvasive neoplastic bronchial lesions. The data of all patients who underwent fluorescence bronchoscopy and in whom bronchial biopsies were taken, were analyzed....

Cite
Venmans BJ, Van Boxem TJ, Smit EF, et al. Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn Ther Endosc. 1999;5(2):77-84doi: 10.1155/DTE.5.77.
Venmans, B. J., Van Boxem, T. J., Smit, E. F., Postmus, P. E., & Sutedja, T. G. (1999). Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagnostic and therapeutic endoscopy, 5(2), 77-84. https://doi.org/10.1155/DTE.5.77
Venmans, B J, et al. "Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia." Diagnostic and therapeutic endoscopy vol. 5,2 (1999): 77-84. doi: https://doi.org/10.1155/DTE.5.77
Venmans BJ, Van Boxem TJ, Smit EF, Postmus PE, Sutedja TG. Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn Ther Endosc. 1999;5(2):77-84. doi: 10.1155/DTE.5.77. PMID: 18493485; PMCID: PMC2362614.
Copy Download .nbib Format: NLM
Severe bronchomalacia in a 65-year-old man treated with stent insertion instead of surgical bronchoplasty.

Diagnostic and therapeutic endoscopy

Sutedja TG, de Graaf JC, Schramel FM, Van Kralingen KW, Postmus PE.
PMID: 18493370
Diagn Ther Endosc. 1995;1(4):227-8. doi: 10.1155/DTE.1.227.

Bronchomalacia in adults is rare. A case is reported here of a 65-year-old man with severe cough and mucostasis, caused by a benign bronchomalacia of the ventral wall of the left main bronchus. This was treated successfully with the...

Cite
Sutedja TG, de Graaf JC, Schramel FM, et al. Severe bronchomalacia in a 65-year-old man treated with stent insertion instead of surgical bronchoplasty. Diagn Ther Endosc. 1995;1(4):227-8doi: 10.1155/DTE.1.227.
Sutedja, T. G., de Graaf, J. C., Schramel, F. M., Van Kralingen, K. W., & Postmus, P. E. (1995). Severe bronchomalacia in a 65-year-old man treated with stent insertion instead of surgical bronchoplasty. Diagnostic and therapeutic endoscopy, 1(4), 227-8. https://doi.org/10.1155/DTE.1.227
Sutedja, T G, et al. "Severe bronchomalacia in a 65-year-old man treated with stent insertion instead of surgical bronchoplasty." Diagnostic and therapeutic endoscopy vol. 1,4 (1995): 227-8. doi: https://doi.org/10.1155/DTE.1.227
Sutedja TG, de Graaf JC, Schramel FM, Van Kralingen KW, Postmus PE. Severe bronchomalacia in a 65-year-old man treated with stent insertion instead of surgical bronchoplasty. Diagn Ther Endosc. 1995;1(4):227-8. doi: 10.1155/DTE.1.227. PMID: 18493370; PMCID: PMC2362491.
Copy Download .nbib Format: NLM
The role of bronchoscopic therapy in bronchial granular cell myoblastoma: presentation of three cases.

Diagnostic and therapeutic endoscopy

van Felius CL, Postmus PE, Beaumont F, Strankinga W, Teengs J, Sutedja TG.
PMID: 18493409
Diagn Ther Endosc. 1996;2(4):223-7. doi: 10.1155/DTE.2.223.

Tracheobronchial granular cell myoblastoma (GCM) is rare. Although the tumor has some malignant properties, it is considered benign, and there is no consensus regarding treatment. Three cases are reported here. Bronchoscopic treatment in patients with GCM may be attempted...

Cite
van Felius CL, Postmus PE, Beaumont F, et al. The role of bronchoscopic therapy in bronchial granular cell myoblastoma: presentation of three cases. Diagn Ther Endosc. 1996;2(4):223-7doi: 10.1155/DTE.2.223.
van Felius, C. L., Postmus, P. E., Beaumont, F., Strankinga, W., Teengs, J., & Sutedja, T. G. (1996). The role of bronchoscopic therapy in bronchial granular cell myoblastoma: presentation of three cases. Diagnostic and therapeutic endoscopy, 2(4), 223-7. https://doi.org/10.1155/DTE.2.223
van Felius, C L, et al. "The role of bronchoscopic therapy in bronchial granular cell myoblastoma: presentation of three cases." Diagnostic and therapeutic endoscopy vol. 2,4 (1996): 223-7. doi: https://doi.org/10.1155/DTE.2.223
van Felius CL, Postmus PE, Beaumont F, Strankinga W, Teengs J, Sutedja TG. The role of bronchoscopic therapy in bronchial granular cell myoblastoma: presentation of three cases. Diagn Ther Endosc. 1996;2(4):223-7. doi: 10.1155/DTE.2.223. PMID: 18493409; PMCID: PMC2362535.
Copy Download .nbib Format: NLM
Video-Assisted Thoracoscopy is Feasible Under Local Anesthesia.

Diagnostic and therapeutic endoscopy

Smit HJ, Schramel FM, Sutedja TG, Ter Laak-Uytenhaak LS, Nannes-Pols MH, Postmus PE.
PMID: 18493470
Diagn Ther Endosc. 1998;4(4):177-82. doi: 10.1155/DTE.4.177.

UNLABELLED: Video-assisted thoracoscopy (VAT) is usually performed under general anesthesia (GA). We performed an analysis to determine whether multithoracoport VAT under local anesthesia (LA) is feasible.METHODS: Forty-five VAT under LA were performed in 34 men and 11 women (mean...

Cite
Smit HJ, Schramel FM, Sutedja TG, et al. Video-Assisted Thoracoscopy is Feasible Under Local Anesthesia. Diagn Ther Endosc. 1998;4(4):177-82doi: 10.1155/DTE.4.177.
Smit, H. J., Schramel, F. M., Sutedja, T. G., Ter Laak-Uytenhaak, L. S., Nannes-Pols, M. H., & Postmus, P. E. (1998). Video-Assisted Thoracoscopy is Feasible Under Local Anesthesia. Diagnostic and therapeutic endoscopy, 4(4), 177-82. https://doi.org/10.1155/DTE.4.177
Smit, H J, et al. "Video-Assisted Thoracoscopy is Feasible Under Local Anesthesia." Diagnostic and therapeutic endoscopy vol. 4,4 (1998): 177-82. doi: https://doi.org/10.1155/DTE.4.177
Smit HJ, Schramel FM, Sutedja TG, Ter Laak-Uytenhaak LS, Nannes-Pols MH, Postmus PE. Video-Assisted Thoracoscopy is Feasible Under Local Anesthesia. Diagn Ther Endosc. 1998;4(4):177-82. doi: 10.1155/DTE.4.177. PMID: 18493470; PMCID: PMC2362601.
Copy Download .nbib Format: NLM
Do You Believe Your Partner is Capable of Killing You? An Examination of Female IPV Survivors' Perceptions of Fatality Risk Indicators.

Journal of interpersonal violence

Johnson L, Cusano JL, Nikolova K, Steiner JJ, Postmus JL.
PMID: 32389054
J Interpers Violence. 2022 Jan;37(1):NP594-NP619. doi: 10.1177/0886260520916273. Epub 2020 May 09.

Advocates in the field of intimate partner violence (IPV) have started to more actively engage survivors around their own perceptions of their lethality risk, as well as assist them in developing strategies for reducing and managing risk related to...

Cite
Johnson L, Cusano JL, Nikolova K, et al. Do You Believe Your Partner is Capable of Killing You? An Examination of Female IPV Survivors' Perceptions of Fatality Risk Indicators. J Interpers Violence. 2020;37(1):NP594-NP619doi: 10.1177/0886260520916273.
Johnson, L., Cusano, J. L., Nikolova, K., Steiner, J. J., & Postmus, J. L. (2022). Do You Believe Your Partner is Capable of Killing You? An Examination of Female IPV Survivors' Perceptions of Fatality Risk Indicators. Journal of interpersonal violence, 37(1), NP594-NP619. https://doi.org/10.1177/0886260520916273
Johnson, Laura, et al. "Do You Believe Your Partner is Capable of Killing You? An Examination of Female IPV Survivors' Perceptions of Fatality Risk Indicators." Journal of interpersonal violence vol. 37,1 (2022): NP594-NP619. doi: https://doi.org/10.1177/0886260520916273
Johnson L, Cusano JL, Nikolova K, Steiner JJ, Postmus JL. Do You Believe Your Partner is Capable of Killing You? An Examination of Female IPV Survivors' Perceptions of Fatality Risk Indicators. J Interpers Violence. 2022 Jan;37(1):NP594-NP619. doi: 10.1177/0886260520916273. Epub 2020 May 09. PMID: 32389054.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 61 entries